Rosiglitazone is a thiazolidinedione-class antidiabetic medication used to improve insulin sensitivity in type 2 diabetes. It acts as a peroxisome proliferator-activated receptor gamma (PPAR-gamma) agonist, influencing glucose and lipid metabolism. Note: its use has declined in many regions due to cardiovascular safety concerns.
Full pronunciation guide
